APA (7th ed.) Citation

MS, K., SY, J., SW, L., H, L., A, K., A, K., . . . L, S. (2021). Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 19(9), 1970. https://doi.org/10.1016/j.cgh.2021.04.039

Chicago Style (17th ed.) Citation

MS, Kim, et al. "Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study." Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 19, no. 9 (2021): 1970. https://doi.org/10.1016/j.cgh.2021.04.039.

MLA (9th ed.) Citation

MS, Kim, et al. "Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study." Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 19, no. 9, 2021, p. 1970, https://doi.org/10.1016/j.cgh.2021.04.039.